BerGenBio ASA: Receipt of subscription rights in the rights issue by primary insiders and their close associates
Bergen 30 May 2023: Reference is made to the stock exchange announcement published by BerGenBio ASA (the "Company") earlier today, 30 May 2023, regarding the commencement of the subscription period in the rights issue (the "Rights Issue"). As part of this process, subscription rights have been allocated to primary insiders and their close associates. Martin Olin, CEO of BerGenBio ASA, has on 30 May 2023 acquired 1 046 125 subscription rights in BerGenBio ASA with no price payable. Anders Tullgren, Chairman of the Board of Directors of BerGenBio ASA, has on 30 May 2023 acquired 1 409